Created in 2003, the Brazilian Medicines Market Regulation Chamber (CMED) is the inter-ministerial body responsible for the economic regulation of the medicines market in Brazil. Among the CMED’s attributions is the definition of the maximum price of service for each drug, for the most part, a model of comparisons with products and costs of national and international treatments.
Regulatory codes and price control of medicines play a fundamental role in systems worldwide and Brazil. It is essential, therefore, to have a clear pricing strategy in place at the health registration stage for successful access to the drug.
Multicare advises its commercial partners in elaborating their access and price plans, sharing the knowledge accumulated in its 38 years of history, maximizing opportunities, and guaranteeing the price generated.
Talk to our commercial team and ensure the best strategy for your company in the Brazilian market.
We are the best option for access to medicines for the treatment of rare or highly complex diseases. We have been present in the pharmaceutical market for 37 years and have become a reference in the area of rare and highly complex diseases in the last decade.
Talk to us: firstname.lastname@example.org
Learn more: www.multicarepharma.com